[{"orgOrder":0,"company":"Faes Farma","sponsor":"Inapplicable","pharmaFlowCategory":"DU","therapeuticArea":"Nutrition and Weight Loss","country":"SPAIN","productType":"Vitamins\/Minerals\/Inorganic Salts","year":"2021","type":"Inapplicable","leadProduct":"Calcifediol","moa":"Vitamin D receptor","graph1":"Nutrition and Weight Loss","graph2":"Phase II\/ Phase III","graph3":"Faes Farma","amount2":0,"highestDevelopmentShortName":"Ph II\/III","therapeuticAreaShortName":"Nutrition & Weight Loss","amount2New":0,"dosageForm":"Oral Capsule","sponsorNew":"Faes Farma \/ Inapplicable","highestDevelopmentStatusID":"9","companyTruncated":"Faes Farma \/ Inapplicable"},{"orgOrder":0,"company":"Abbott Laboratories","sponsor":"Inapplicable","pharmaFlowCategory":"DU","therapeuticArea":"Nutrition and Weight Loss","country":"U.S.A","productType":"Dietary Supplement","year":"2023","type":"Inapplicable","leadProduct":"Nutritional Supplement","moa":"Undisclosed","graph1":"Nutrition and Weight Loss","graph2":"Phase II\/ Phase III","graph3":"Abbott Laboratories","amount2":0,"highestDevelopmentShortName":"Ph II\/III","therapeuticAreaShortName":"Nutrition & Weight Loss","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Abbott Laboratories \/ Inapplicable","highestDevelopmentStatusID":"9","companyTruncated":"Abbott Laboratories \/ Inapplicable"}]

Find Clinical Drug Development Pipelines & Deals | PipelineProspector

Xls
Filters Filter
×
FILTER:
filter
Company Name
    filter

    Year

      filter

      DEALS // DEV.

        filter

        Country

          filter
          Sponsor
            filter

            Therapeutic Area

              filter

              Study Phase

                filter

                Deal Type

                  filter

                  Product Type

                    filter

                    Dosage Form

                      filter

                      Lead Product

                        filter

                        Target

                          Loading...

                          Therapeutic Area by Lead Product

                          Study Phase by Lead Product

                          Company by Lead Product

                          Top Deals by Deal Size (USD bn)

                          01

                          CPhI Korea
                          Not Confirmed
                          CPhI Korea
                          Not Confirmed

                          Details : Undisclosed

                          Product Name : Undisclosed

                          Product Type : Other Small Molecule

                          Upfront Cash : Inapplicable

                          April 04, 2025

                          Lead Product(s) : Choline Chloride

                          Therapeutic Area : Nutrition and Weight Loss

                          Highest Development Status : Phase II/ Phase III

                          Sponsor : Inapplicable

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          02

                          CPhI Korea
                          Not Confirmed
                          CPhI Korea
                          Not Confirmed

                          Details : Undisclosed

                          Product Name : Undisclosed

                          Product Type : Vitamins/Minerals/Inorganic Salts

                          Upfront Cash : Inapplicable

                          February 03, 2021

                          Lead Product(s) : Calcifediol

                          Therapeutic Area : Nutrition and Weight Loss

                          Highest Development Status : Phase II/ Phase III

                          Sponsor : Inapplicable

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          03

                          CPhI Korea
                          Not Confirmed
                          CPhI Korea
                          Not Confirmed

                          Details : Undisclosed

                          Product Name : Undisclosed

                          Product Type : Protein

                          Upfront Cash : Inapplicable

                          August 29, 2018

                          Lead Product(s) : Setmelanotide Acetate

                          Therapeutic Area : Nutrition and Weight Loss

                          Highest Development Status : Phase II/ Phase III

                          Sponsor : Inapplicable

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          04

                          CPhI Korea
                          Not Confirmed
                          CPhI Korea
                          Not Confirmed

                          Details : Undisclosed

                          Product Name : Undisclosed

                          Product Type : Dietary Supplement

                          Upfront Cash : Inapplicable

                          August 14, 2015

                          Lead Product(s) : Nutritional Supplement

                          Therapeutic Area : Nutrition and Weight Loss

                          Highest Development Status : Phase II/ Phase III

                          Sponsor : Inapplicable

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          05

                          Centre For International Health

                          Country arrow
                          CPhI Korea
                          Not Confirmed

                          Centre For International Health

                          Country arrow
                          CPhI Korea
                          Not Confirmed

                          Details : Undisclosed

                          Product Name : Undisclosed

                          Product Type : Vitamins/Minerals/Inorganic Salts

                          Upfront Cash : Inapplicable

                          October 23, 2014

                          Lead Product(s) : Vitamin B12

                          Therapeutic Area : Nutrition and Weight Loss

                          Highest Development Status : Phase II/ Phase III

                          Sponsor : Tribhuvan University, Nepal | NORCE Norwegian Research Centre AS

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          06

                          Catalysis

                          Country arrow
                          CPhI Korea
                          Not Confirmed

                          Catalysis

                          Country arrow
                          CPhI Korea
                          Not Confirmed

                          Details : Undisclosed

                          Product Name : Undisclosed

                          Product Type : Dietary Supplement

                          Upfront Cash : Inapplicable

                          May 23, 2014

                          Lead Product(s) : Obex

                          Therapeutic Area : Nutrition and Weight Loss

                          Highest Development Status : Phase II/ Phase III

                          Sponsor : Inapplicable

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          07

                          Catalysis

                          Country arrow
                          CPhI Korea
                          Not Confirmed

                          Catalysis

                          Country arrow
                          CPhI Korea
                          Not Confirmed

                          Details : Undisclosed

                          Product Name : Undisclosed

                          Product Type : Dietary Supplement

                          Upfront Cash : Inapplicable

                          September 04, 2013

                          Lead Product(s) : Obex

                          Therapeutic Area : Nutrition and Weight Loss

                          Highest Development Status : Phase II/ Phase III

                          Sponsor : Inapplicable

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          08

                          International Centre for Diarrhoeal Disease Research, Bangladesh

                          Country arrow
                          CPhI Korea
                          Not Confirmed

                          International Centre for Diarrhoeal Disease Research, Bangladesh

                          Country arrow
                          CPhI Korea
                          Not Confirmed

                          Details : Undisclosed

                          Product Name : Undisclosed

                          Product Type : Dietary Supplement

                          Upfront Cash : Inapplicable

                          June 28, 2013

                          Lead Product(s) : Rutf-1

                          Therapeutic Area : Nutrition and Weight Loss

                          Highest Development Status : Phase II/ Phase III

                          Sponsor : UNICEF | Nutriset

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          09

                          Roquette Freres

                          Country arrow
                          CPhI Korea
                          Not Confirmed

                          Roquette Freres

                          Country arrow
                          CPhI Korea
                          Not Confirmed

                          Details : Undisclosed

                          Product Name : Undisclosed

                          Product Type : Dietary Supplement

                          Upfront Cash : Inapplicable

                          January 08, 2010

                          Lead Product(s) : Maltodextrin

                          Therapeutic Area : Nutrition and Weight Loss

                          Highest Development Status : Phase II/ Phase III

                          Sponsor : Sprim Advanced Life Sciences

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank